期刊文献+

PTEN基因转染对卵巢癌A2780细胞周期和增殖能力影响的研究 被引量:3

Effect of transfected PTEN gene on cell cycle and proliferation of human ovarian cancer cell line A2780
下载PDF
导出
摘要 目的:研究外源性PTEN基因稳定转染对人卵巢癌A2780细胞周期和增殖能力的影响。方法:构建PTEN基因的野生型真核表达质粒pEGFP-C1-WT-PTEN和突变型表达质粒pEG-FP-C1-C124A-PTEN,以脂质体介导法转染体外培养的人卵巢癌细胞株A2780,同时转染空载体pEGFP-C1质粒,以未转染细胞为对照(转染成功后分别命名为WT-PTEN/A2780组、C124A-PTEN/A2780组、pEGFP-C1/A2-780组和A2780组。应用RT-PCR、Western blot方法分析目的基因及其蛋白表达,并采用MTT法和流式细胞术检测细胞增殖和细胞周期。结果:与对照细胞相比,WT-PTEN/A2780组和C124A-PTEN/A2780组PTEN mRNA及PTEN蛋白出现明显的高表达,与对照组细胞相比差异有统计学意义(t=5.300,P=0.034;t=11.963,P=0.007;t=7.869,P=0.016;t=22.421,P=0.002);WT-PTEN/A2780组细胞生长速度明显慢于未转染A2780细胞,然而C124A-PTEN/A2780组和pEGFP-C1/A2780组细胞生长速度无明显变化。流式细胞术显示WT-PTEN/A2780细胞G1期细胞数增加到(71.18±4.34)%,S期细胞数变为(17.48±1.96)%,与对照组相比差异有统计学意义(t=19.508,P=0.003;t=25.354,P=0.002),提示从G1期到S期发生抑制。结论:野生型PTEN可依赖其磷酸酶活性使A2780细胞在G1/S期发生细胞周期阻滞,并抑制A2780细胞增殖。 OBJECTIVE: To investigate the effects of exogenous wild PTEN gene stably transfection on the cell cycle and proliferation in human ovarian cancer cell line A2780. METHODS: Wild-type PTEN and mutant PTEN recombinant eukaryotic expression plasmids were constructed, then they and the empty vector were transfected into A2780 cells by lipofectamine. The cell non transfected was considered as the control (four groups were named as WT-PTEN/A2780, C124A-PTEN/A2780, pEGFP-C1/A2780 and A2780 ). RT-PCR and Western blot were used to determine the target gene and protein expression, the cell viability was tested by MTT assay, and the cell cycle was determined by flow cytometry. RESULTS.. Compared with the control, WT PTEN/A2780 group and C124A-PTEN/A2780 group demonstrated high expression of PTEN mRNA and protein (t=5.300,P=0.034; t= 11. 963 , P= 0. 007 ; t=7.869,P= 0.016; t:22.421,P:0.002). The proliferation speed of WT-PTEN/A2780 was obviously slower than those of nontransfected cells. The proliferation speed did not change obriously in C124A PTEN/A2780 group and pEGFP-C1/A2780 group. Flow cytometry showed that in WT-PTEN/A2780 group, the cells of G1 phase was (71.18±4.34)%, the cells of S phase was (17.48±1.96)%, and were significantly dif- ferent from those of control group (t= 19. 508, P= 0. 003; t=25. 354, P=0. 002). The progression of cell cycle was ar rested from G1 to S phases. CONCLUSION.. The growth of A2780 cells could be arrested at G1/S phase and be suppressed by phosphatase activity of exogenous PTEN gene.
出处 《中华肿瘤防治杂志》 CAS 2007年第23期1761-1765,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金资助项目(30571950) 国家973重点基础研究发展计划资助项目(2002CB513107)
关键词 卵巢肿瘤 PTEN基因 增殖 细胞周期 ovarian neoplasms PTEN gene proliferation cell cycle
  • 相关文献

参考文献13

  • 1Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997, 275(5308) : 1943-1947.
  • 2魏法才,陈启,杨道贵,隋永领.胃癌组织中PTEN和VEGF的表达及其相关性[J].中华肿瘤防治杂志,2007,14(8):601-603. 被引量:9
  • 3陈颖,赵雨杰,郑华川,杨雪飞,张淑兰,辛彦.PTEN与VEGF_(165)基因mRNA在卵巢癌中表达及相关性研究[J].肿瘤防治杂志,2003,10(12):1244-1247. 被引量:1
  • 4Chu E C, Tarnawski A S. PTEN regulatory functions in tumour suppression and cell biology[J]. Med Sci Monit, 2004,10(10): 235-241.
  • 5周蔚,李留霞.卵巢癌的靶向基因治疗研究进展[J].国外医学(妇产科学分册),2006,33(5):324-327. 被引量:3
  • 6Waite K A, Eng C. Protein PTEN: form and function [J]. Am J Hum Genet, 2002, 70(4) :829-844.
  • 7Davies M A, Lu Y, Sano T, et al. Adenoviral transgene expression of MMAC/ PTEN in human glioma cells inhibits Akt activation and inducesanoikis[J]. Cancer Res, 1998, 58(23): 5285-5290.
  • 8Tamura M, Gu J, Takjno T, et al. Tumor suppressor PTEN inhibtionof cell invasion, migration, and growth: differential involvement of focal adhesion kinase and P130Cas[J]. Cancer Res, 1999, 59(2): 442-449.
  • 9Carmichael J, DeGraff W G, Gazadar A F, et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay., assessment of chemosensitivity testing [J]. Cancer Res, 1987, 47 (4) : 936-942.
  • 10Cantley L C, Neel B G. New insights into tumour suppression: PTEN suppresses tumour formation by restraining the phosphoinositide 3-kinase/A KT pathway [J]. Proc Natl Acad Sci USA , 1999, 96(8): 4240-4245.

二级参考文献33

  • 1马凤江,智绪亭.血管内皮生长因子-C在胃癌组织中的表达及与肿瘤淋巴结转移的关系[J].肿瘤防治杂志,2005,12(4):281-282. 被引量:12
  • 2Breidenbach M,Rein DT,Glasgow JN,et al.Mesothelin-mediated targeting of adenoviral vec-tors for ovarian gene therapy.Gene Ther,2005,12(2):187-193
  • 3Mivamoto S,Hirata M,Yamazaki A,et al.Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.Cancer Res,2004,64(16):5720-5727
  • 4Shen Z,Wu M,Elson P,et al.Fatty acid composition of lysophosphatidic acid and lysophosph-atidylinosital in plasma from patients with ovarian cancer and other gynecological diseases.Gynecol Oncol,2001,83(1):25-30
  • 5Tanyi JL,MorrisAT,Wolf JK,et al.The human lipid phosphate phosphatase-3 decreases the growth,survival,and tumorigenesis of ovarian cancer cells:validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.Cancer Res,2003,63(5):1073-1082
  • 6Ziller C,Lincet H,Muller CD,et al.The cyclin-dependent kinase inhibitor p21cip1/waf1 enhances the cytotoxicity of ganciclovir in HSV-tk transfected ovarian carcinoma cells.Cancer Lett,2004,212(1):43-52
  • 7Rancourt C,Bergeron C,Lane D,et al.Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.Cytotherapy,2003,5(6):509-522
  • 8Schutze N.siRNA technology.Mol Cell Endocrinol,2004,213(2):115-119
  • 9Tsuchiya A,Sakamoto M,Yasuda J,et al.Expression profiling in ovarian clear cell carcinoma:identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovary clear cell carcinoma.Am J Pathol,2003,163(6):2503-2512
  • 10Menendez JA,Vellon L,Mehmi I,et al.Ihibition of fatty acid synthase (FAS) suppresses HER2/ neu (erbB-2) oncogene overexpression in cancer cells.Proc Natl Acad Sci U S A,2004,101 (29):10715-10720

共引文献10

同被引文献25

  • 1郁宝铭.进一步提高直肠癌疗效的策略[J].中华肿瘤防治杂志,2007,14(2):81-84. 被引量:10
  • 2Popovici C, Zhang B, Gregoire MJ,et al. The t(6;8)(q27;p11) translocation in a stem ceil myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1[J]. Blood, 1999,93(4) :1381-1389.
  • 3Mikolajka A, Yan X, Popowicz G M, et al. Structure of the N- terminal domain of lhe FOP (FGFRIOP) protein and implications for its dimerization and centrosomal localization[J]. J Mol Biol, 2006,359(4) : 863-875.
  • 4Guasch G, Ollendorff V, Borg J P, et al. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t (6 ; 8) translocation induces cell survival mediated by mitogen activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways[J]. Mol Cell Biol, 2001, 21(23) :8129-8142.
  • 5Mano Y, Takahashi K, Ishikawa N, et al. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer[J]. Cancer Sci,2007, 98(12):1902-1913.
  • 6Yanagi S, Kishimoto H, Kawahara K, et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice[J]. J Clin Invest, 2007,117(10):2929- 2940.
  • 7Iwanaga K, Yang Y, Raso M G, et al. Pten inactivation accelerates oncogenic K-ras initiated tumorigenesis in a mouse model of lung cancer[J]. Cancer Res, 2008,68(4) :1119-1127.
  • 8Marsit C J, Zheng S, Aldape K, et al. PTEN expression in non- small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration[J]. Hum Pathol, 2005,36 (7) : 768-776.
  • 9Noro R, Gemma A, Miyanaga A, et al. PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors[J]. Int J Oncol, 2007,31(5) :1157-1163.
  • 10Yamasaki F, Johansen M J, Zhang D, et al. Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regu lation of MMAC1/PTEN and up regulation of phosphorylated Akt[J]. Cancer Res, 2007,67 (12) :5779-5788.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部